BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 8855296)

  • 1. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process.
    Ahn K; Angulo A; Ghazal P; Peterson PA; Yang Y; Früh K
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10990-5. PubMed ID: 8855296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.
    Hegde NR; Tomazin RA; Wisner TW; Dunn C; Boname JM; Lewinsohn DM; Johnson DC
    J Virol; 2002 Nov; 76(21):10929-41. PubMed ID: 12368336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11.
    Pande NT; Powers C; Ahn K; Früh K
    J Virol; 2005 May; 79(9):5786-98. PubMed ID: 15827193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus.
    Johnson DC; Hegde NR
    Curr Top Microbiol Immunol; 2002; 269():101-15. PubMed ID: 12224504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cytomegalovirus immediate early glycoprotein US3 retains MHC class I molecules by transient association.
    Gruhler A; Peterson PA; Früh K
    Traffic; 2000 Apr; 1(4):318-25. PubMed ID: 11208117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cytomegalovirus US3 modulates destruction of MHC class I molecules.
    Noriega VM; Hesse J; Gardner TJ; Besold K; Plachter B; Tortorella D
    Mol Immunol; 2012 Jun; 51(2):245-53. PubMed ID: 22497807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains.
    Jones TR; Sun L
    J Virol; 1997 Apr; 71(4):2970-9. PubMed ID: 9060656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placental extravillous cytotrophoblasts persistently express class I major histocompatibility complex molecules after human cytomegalovirus infection.
    Terauchi M; Koi H; Hayano C; Toyama-Sorimachi N; Karasuyama H; Yamanashi Y; Aso T; Shirakata M
    J Virol; 2003 Aug; 77(15):8187-95. PubMed ID: 12857887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains.
    Jones TR; Wiertz EJ; Sun L; Fish KN; Nelson JA; Ploegh HL
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11327-33. PubMed ID: 8876135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MHC class I homolog of human cytomegalovirus is resistant to down-regulation mediated by the unique short region protein (US)2, US3, US6, and US11 gene products.
    Park B; Oh H; Lee S; Song Y; Shin J; Sung YC; Hwang SY; Ahn K
    J Immunol; 2002 Apr; 168(7):3464-9. PubMed ID: 11907106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cytomegalovirus US3 chimeras containing US2 cytosolic residues acquire major histocompatibility class I and II protein degradation properties.
    Chevalier MS; Johnson DC
    J Virol; 2003 Apr; 77(8):4731-8. PubMed ID: 12663780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cytomegalovirus: host immune modulation by the viral US3 gene.
    Liu Z; Winkler M; Biegalke B
    Int J Biochem Cell Biol; 2009 Mar; 41(3):503-6. PubMed ID: 18992841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP.
    Ahn K; Gruhler A; Galocha B; Jones TR; Wiertz EJ; Ploegh HL; Peterson PA; Yang Y; Früh K
    Immunity; 1997 May; 6(5):613-21. PubMed ID: 9175839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of human cytomegalovirus US2 to major histocompatibility complex class I and II proteins is not sufficient for their degradation.
    Chevalier MS; Daniels GM; Johnson DC
    J Virol; 2002 Aug; 76(16):8265-75. PubMed ID: 12134032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal peptide-dependent inhibition of MHC class I heavy chain translation by rhesus cytomegalovirus.
    Powers CJ; Früh K
    PLoS Pathog; 2008 Oct; 4(10):e1000150. PubMed ID: 18833297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Macrophages Escape Inhibition of Major Histocompatibility Complex-Dependent Antigen Presentation by Cytomegalovirus and Drive Proliferation and Activation of Memory CD4
    Frascaroli G; Lecher C; Varani S; Setz C; van der Merwe J; Brune W; Mertens T
    Front Immunol; 2018; 9():1129. PubMed ID: 29887865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MHC class I-subversive gene functions of cytomegalovirus and their regulation by interferons-an intricate balance.
    Benz C; Hengel H
    Virus Genes; 2000; 21(1-2):39-47. PubMed ID: 11022788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HCMV gene products US2 and US11 target MHC class I molecules for degradation in the cytosol.
    van der Wal FJ; Kikkert M; Wiertz E
    Curr Top Microbiol Immunol; 2002; 269():37-55. PubMed ID: 12224515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cytomegalovirus pp71 stimulates major histocompatibility complex class i presentation of IE1-derived peptides at immediate early times of infection.
    Hesse J; Reyda S; Tenzer S; Besold K; Reuter N; Krauter S; Büscher N; Stamminger T; Plachter B
    J Virol; 2013 May; 87(9):5229-38. PubMed ID: 23449799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol.
    Wiertz EJ; Jones TR; Sun L; Bogyo M; Geuze HJ; Ploegh HL
    Cell; 1996 Mar; 84(5):769-79. PubMed ID: 8625414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.